Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds
Information source: Banner Health
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Wounds
Intervention: morphine topical gel (Drug); placebo (Drug)
Phase: Phase 3
Status: Not yet recruiting
Sponsored by: Banner Health Official(s) and/or principal investigator(s):
Mary Whitmer, MSN,FNP, APRN BC-PCM, Principal Investigator, Affiliation: Banner Health
Overall contact:
Mary Whitmer, FNP, Phone: 602-239-6078, Email: marywhitmer@bannerhealth.com
Summary
Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of
oral and intravenous pain medications, therefore reducing side effects.
Clinical Details
Official title: A Phase 3, Single-Centered, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Trial of Morphine Sulfate Gel 0.1% in Patients With Stage 2-3 Wounds
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Safety and efficacy with the use of morphine gel applied topically for pain control
Detailed description:
Patients will be randomized to receive either placebo (versa base gel) or morphine gel to
wound. Patients receiving morphine gel will have a decrease in pain score and use less
oral/intravenous pain medications.
Eligibility
Minimum age: 18 Years.
Maximum age: 75 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Signed and dated consent form & HIPAA
- > 18 yo
- Single stage 2-3 wound
- No allergy to morphine
- Alert and oriented (thinking ability clear and intact, physician approval)
- English language proficiency
Exclusion Criteria:
- Allergy to morphine, codeine, or versa base, pts taking medications for acute
condition, other than for the wound pain
- Patients with neuropathies
- Patients with respiratory conditions
Locations and Contacts
Mary Whitmer, FNP, Phone: 602-239-6078, Email: marywhitmer@bannerhealth.com
Banner Good Samaritan Medical Center, Phoenix, Arizona 85006, United States; Not yet recruiting
Whitmer, Phone: 602-239-6078
Additional Information
Starting date: December 2008
Last updated: September 18, 2008
|
